Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples